Cite Filings / SMMT / 0001193125-25-256643
Feed Companies Filings Check
Sign in
S-3ASR

Registration Statement

Summit Therapeutics Inc. · Filed 2025-10-29 · Acc 0001193125-25-256643

Documents 1

  • S-3ASR Registration Statement , d79902ds3asr.htm

Around this filing

  • 2026-06-09 S-3ASR Registration Statement
  • 2025-10-29 S-3ASR Registration Statement
  • 2025-10-23 4 Director bought 533,617 shares at $18.74 ($9,999,983)
  • 2025-10-23 4 Chief Accounting Officer acquired 26,680 shares (grant or award)
  • 2025-10-23 4 COO and CFO acquired 53,361 shares (grant or award)
  • 2025-10-23 4 Co-Chief Executive Officer bought 26,680 shares at $18.74 ($499,983)
  • 2024-09-19 S-3ASR Registration Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading d79902ds3asr.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…